Frequency Therapeutics Inc. (FREQ) Fundamentals

Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.
SHARE INFORMATION
Market Cap$ 69,952,818
Shares Outstanding34,976,409
Float32,243,206
Percent Float92.19%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 14,068,000
Latest Fiscal EPS$ -2.48
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions251
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months1,532,633
Institutional Holdings Percent69.8%
Institutional Sold Previous 3 Months10,776,433
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months159,076
Insider Holdings Percent3.4
Insider Sold Previous 3 Months93,227
Insider Shares Owned1,194,487
TRADING INFO
52 Week High$ 8.45
52 Week Low$ 1.00
52 Week High Change$ -76.08
21 Day Moving Average$ 2.1214
21 Day Extended Moving Average$ 2.0157
50 Day Moving Average$ 1.6614
50 Day Extended Moving Average$ 1.8475
200 Day Moving Average$ 3.3083
200 Day Extended Moving Average$ 3.9435
10 Day Average Volume193,326
20 Day Average Volume334,526
30 Day Average Volume442,183
50 Day Average Volume534,439
Alpha-0.019529
Beta0.7741
Standard Deviation0.256612
R20.030356
7 Day Price Change$ 0.08
7 Day Percent Change4.17%
21 Day Price Change$ -0.08
21 Day Percent Change-3.85%
30 Day Price Change$ 0.11
30 Day Percent Change5.82%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ 0.50
Quarter to Date Percent Change33.33%
180 Day Price Change$ -2.88
180 Day Percent Change-59.02%
200 Day Price Change$ -2.82
200 Day Percent Change-58.51%
Year to Date Price Change$ -3.13
Year to Date Percent Change-61.01%

Frequency Therapeutics Inc. (FREQ) Key Ratios

PROFITABILITY
EBIT Margin-923.3%
EBITDA Margin-890.2%
Pre-Tax Profit Margin0.0%
Profit Margin Count-72.67%
Gross Margin0.0%
Profit Margin TOT-72.67%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.70
Total Debt To Equity0.40
Int Coverage-120.10
Current Ratio9.90
Leverage Ratio1.40
Quick Ratio9.60
Long Term Debt To Capital0.26
VALUATION MEASURES
PE Ratio-0.90
Enterprise Value$ 6,521,920
Price to Sales0.00
Price to Free Cash-1.60
PE High Last 5 Years0.00
Price To Book0.70
Price To Cash Flow28.20
PE Low Last 5 Years0.00
Price to Tangible Book0.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-43.15
Return on Equity-60.46
Return on Capital-45.86

Frequency Therapeutics Inc. (FREQ) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorRSM US LLP
CEODavid L. Lucchino
Emplyoees74
Last AuditUQ
CIK0001703647
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address75 Hayden Avenue
Suite 300
Lexington, MA 2421
Websitehttps://www.frequencytx.com
Facsimile-
Telephone+1 866 389-1970
Emailinvestorrelations@frequencytx.com


Your Recent History
NASDAQ
FREQ
Frequency ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.